Recent press featuring Tenvie

We're excited to share that Tenvie announcements have been picked up in the press recently!

The promotion of Tony Estrada by Tenvie's Board was featured in Yahoo! Finance, BioCentury, and BioWorld

Our great news has also been picked up by Endpoints News, Fierce Biotech's Chutes and Ladders, as well as STAT's Up and down the ladder

→" Tenvie Therapeutics has installed co-founder and CSO Tony Estrada as CEO of the company. Tenvie had been running without a chief exec since its inception, and Estrada had told Endpoints’ Kyle LaHucik back in January that the company didn’t have any near-term plans to do so. Formerly known as NICO Therapeutics, Tenvie launched early this year with $200 million in its pockets and a suite of preclinical programs that formerly belonged to Denali Therapeutics, a company where Estrada had previously spent nearly nine years."